205 related articles for article (PubMed ID: 19953083)
1. Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure.
Barraza RA; McLaren JW; Poeschla EM
Mol Ther; 2010 Mar; 18(3):491-501. PubMed ID: 19953083
[TBL] [Abstract][Full Text] [Related]
2. Genetic modification of human trabecular meshwork with lentiviral vectors.
Loewen N; Fautsch MP; Peretz M; Bahler CK; Cameron JD; Johnson DH; Poeschla EM
Hum Gene Ther; 2001 Nov; 12(17):2109-19. PubMed ID: 11747600
[TBL] [Abstract][Full Text] [Related]
3. Long-term, targeted genetic modification of the aqueous humor outflow tract coupled with noninvasive imaging of gene expression in vivo.
Loewen N; Fautsch MP; Teo WL; Bahler CK; Johnson DH; Poeschla EM
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3091-8. PubMed ID: 15326125
[TBL] [Abstract][Full Text] [Related]
4. Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates.
Barraza RA; Rasmussen CA; Loewen N; Cameron JD; Gabelt BT; Teo WL; Kaufman PL; Poeschla EM
Hum Gene Ther; 2009 Mar; 20(3):191-200. PubMed ID: 19301472
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes.
Shepard AR; Millar JC; Pang IH; Jacobson N; Wang WH; Clark AF
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2067-76. PubMed ID: 19959644
[TBL] [Abstract][Full Text] [Related]
6. Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail.
Kaufman PL
Exp Eye Res; 2008 Jan; 86(1):3-17. PubMed ID: 18053986
[TBL] [Abstract][Full Text] [Related]
7. Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice.
Millar JC; Savinainen A; Josiah S; Pang IH
Exp Eye Res; 2019 Nov; 188():107763. PubMed ID: 31421135
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer to the outflow tract.
Dang Y; Loewen R; Parikh HA; Roy P; Loewen NA
Exp Eye Res; 2017 May; 158():73-84. PubMed ID: 27131906
[TBL] [Abstract][Full Text] [Related]
9. The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment.
Braunger BM; Fuchshofer R; Tamm ER
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):173-81. PubMed ID: 25957840
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostaglandins on the aqueous humor outflow pathways.
Weinreb RN; Toris CB; Gabelt BT; Lindsey JD; Kaufman PL
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S53-64. PubMed ID: 12204701
[TBL] [Abstract][Full Text] [Related]
11. Durable, safe, multi-gene lentiviral vector expression in feline trabecular meshwork.
Khare PD; Loewen N; Teo W; Barraza RA; Saenz DT; Johnson DH; Poeschla EM
Mol Ther; 2008 Jan; 16(1):97-106. PubMed ID: 17912236
[TBL] [Abstract][Full Text] [Related]
12. [The progress of aqueous humor outflow pathway in open-angle glaucoma].
An L; Ji J
Zhonghua Yan Ke Za Zhi; 2011 Oct; 47(10):953-6. PubMed ID: 22321508
[TBL] [Abstract][Full Text] [Related]
13. Treatment of glaucoma by prostaglandin agonists and beta-blockers in combination directly reduces pro-fibrotic gene expression in trabecular meshwork.
Tejwani S; Machiraju P; Nair AP; Ghosh A; Das RK; Ghosh A; Sethu S
J Cell Mol Med; 2020 May; 24(9):5195-5204. PubMed ID: 32267082
[TBL] [Abstract][Full Text] [Related]
14. New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland.
Coca-Prados M; Escribano J
Prog Retin Eye Res; 2007 May; 26(3):239-62. PubMed ID: 17321191
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes.
Maihöfner C; Schlötzer-Schrehardt U; Gühring H; Zeilhofer HU; Naumann GO; Pahl A; Mardin C; Tamm ER; Brune K
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2616-24. PubMed ID: 11581208
[TBL] [Abstract][Full Text] [Related]
16. Elevation of intraocular pressure in rodents using viral vectors targeting the trabecular meshwork.
Pang IH; Millar JC; Clark AF
Exp Eye Res; 2015 Dec; 141():33-41. PubMed ID: 26025608
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9.
Wu J; Bell OH; Copland DA; Young A; Pooley JR; Maswood R; Evans RS; Khaw PT; Ali RR; Dick AD; Chu CJ
Mol Ther; 2020 Mar; 28(3):820-829. PubMed ID: 31981492
[TBL] [Abstract][Full Text] [Related]
18. Senescent phenotype of trabecular meshwork cells displays biomarkers in primary open-angle glaucoma.
Babizhayev MA; Yegorov YE
Curr Mol Med; 2011 Oct; 11(7):528-52. PubMed ID: 21707516
[TBL] [Abstract][Full Text] [Related]
19. Advances in glaucoma diagnosis and therapy for the next millennium: new drugs for trabecular and uveoscleral outflow.
Kaufman PL; Gabelt B; Tian B; Liu X
Semin Ophthalmol; 1999 Sep; 14(3):130-43. PubMed ID: 10790577
[TBL] [Abstract][Full Text] [Related]
20. Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.
O'Callaghan J; Cassidy PS; Humphries P
Expert Opin Ther Targets; 2017 Nov; 21(11):1037-1050. PubMed ID: 28952395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
